InflaRx pauses phase 3 trial activities for vilobelimab, seeks clarity on FDA advice
February 28 2022 - 8:59AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
InflaRx NV (NASDAQ:IFRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
InflaRx NV (NASDAQ:IFRX)
Historical Stock Chart
From Sep 2023 to Sep 2024